Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Cutting edge: Nlrp10 is essential for protective antifungal adaptive immunity against Candida albicans.

Joly S, Eisenbarth SC, Olivier AK, Williams A, Kaplan DH, Cassel SL, Flavell RA, Sutterwala FS.

J Immunol. 2012 Nov 15;189(10):4713-7. doi: 10.4049/jimmunol.1201715.

2.

The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis.

van de Veerdonk FL, Joosten LA, Shaw PJ, Smeekens SP, Malireddi RK, van der Meer JW, Kullberg BJ, Netea MG, Kanneganti TD.

Eur J Immunol. 2011 Aug;41(8):2260-8. doi: 10.1002/eji.201041226.

3.

Caspase-8 modulates dectin-1 and complement receptor 3-driven IL-1β production in response to β-glucans and the fungal pathogen, Candida albicans.

Ganesan S, Rathinam VA, Bossaller L, Army K, Kaiser WJ, Mocarski ES, Dillon CP, Green DR, Mayadas TN, Levitz SM, Hise AG, Silverman N, Fitzgerald KA.

J Immunol. 2014 Sep 1;193(5):2519-30. doi: 10.4049/jimmunol.1400276.

4.

A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans.

Tomalka J, Ganesan S, Azodi E, Patel K, Majmudar P, Hall BA, Fitzgerald KA, Hise AG.

PLoS Pathog. 2011 Dec;7(12):e1002379. doi: 10.1371/journal.ppat.1002379.

5.

Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome.

Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS.

J Immunol. 2009 Sep 15;183(6):3578-81. doi: 10.4049/jimmunol.0901323.

6.

Adaptive immune responses to Candida albicans infection.

Richardson JP, Moyes DL.

Virulence. 2015;6(4):327-37. doi: 10.1080/21505594.2015.1004977. Review.

7.

CD47 Promotes Protective Innate and Adaptive Immunity in a Mouse Model of Disseminated Candidiasis.

Navarathna DH, Stein EV, Lessey-Morillon EC, Nayak D, Martin-Manso G, Roberts DD.

PLoS One. 2015 May 26;10(5):e0128220. doi: 10.1371/journal.pone.0128220.

8.

NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells.

Eisenbarth SC, Williams A, Colegio OR, Meng H, Strowig T, Rongvaux A, Henao-Mejia J, Thaiss CA, Joly S, Gonzalez DG, Xu L, Zenewicz LA, Haberman AM, Elinav E, Kleinstein SH, Sutterwala FS, Flavell RA.

Nature. 2012 Apr 25;484(7395):510-3. doi: 10.1038/nature11012. Erratum in: Nature. 2016 Feb 25;530(7591):504.

9.

Protective effect of Artin M from extract of Artocarpus integrifolia seeds by Th1 and Th17 immune response on the course of infection by Candida albicans.

Custodio LA, Loyola W, Conchon-Costa I, da Silva Quirino GF, Felipe I.

Int Immunopharmacol. 2011 Oct;11(10):1510-5. doi: 10.1016/j.intimp.2011.05.005.

10.

An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans.

Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA.

Cell Host Microbe. 2009 May 8;5(5):487-97. doi: 10.1016/j.chom.2009.05.002.

11.

Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan.

Kumar H, Kumagai Y, Tsuchida T, Koenig PA, Satoh T, Guo Z, Jang MH, Saitoh T, Akira S, Kawai T.

J Immunol. 2009 Dec 15;183(12):8061-7. doi: 10.4049/jimmunol.0902477.

12.

Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection.

Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S.

J Immunol. 2013 Jan 15;190(2):521-5. doi: 10.4049/jimmunol.1202924.

13.

Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections.

Hernández-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, Gaffen SL.

Mucosal Immunol. 2013 Sep;6(5):900-10. doi: 10.1038/mi.2012.128.

14.

Roles of NLRP10 in innate and adaptive immunity.

Damm A, Lautz K, Kufer TA.

Microbes Infect. 2013 Jun;15(6-7):516-23. doi: 10.1016/j.micinf.2013.03.008. Review.

PMID:
23562614
15.

B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans.

Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH, Romani L.

J Immunol. 2002 Dec 1;169(11):6298-308.

16.

Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy.

Vonk AG, Netea MG, van der Meer JW, Kullberg BJ.

Expert Opin Biol Ther. 2006 Sep;6(9):891-903. Review.

PMID:
16918256
17.

The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections.

Bishu S, Hernández-Santos N, Simpson-Abelson MR, Huppler AR, Conti HR, Ghilardi N, Mamo AJ, Gaffen SL.

Infect Immun. 2014 Mar;82(3):1173-80. doi: 10.1128/IAI.01335-13.

18.

Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation.

Bacci A, Montagnoli C, Perruccio K, Bozza S, Gaziano R, Pitzurra L, Velardi A, d'Ostiani CF, Cutler JE, Romani L.

J Immunol. 2002 Mar 15;168(6):2904-13.

19.

CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis.

Mencacci A, Montagnoli C, Bacci A, Cenci E, Pitzurra L, Spreca A, Kopf M, Sharpe AH, Romani L.

J Immunol. 2002 Sep 15;169(6):3180-90.

20.

IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection.

Mencacci A, Cenci E, Del Sero G, Fé d'Ostiani C, Mosci P, Trinchieri G, Adorini L, Romani L.

J Immunol. 1998 Dec 1;161(11):6228-37.

Supplemental Content

Support Center